Background: Selective serotonin reuptake inhibitors (SSRIs) are commonly used to treat
pediatric anxiety disorders, including generalized anxiety disorder (GAD); however, their …

Objective: Generalized anxiety disorder (GAD) in children and adolescents is associated
with substantial morbidity and increases the risk of future psychopathology. However …

In pediatric patients, the selective serotonin reuptake inhibitors (SSRIs) escitalopram and
citalopram (es/citalopram) are commonly prescribed for anxiety and depressive disorders …

Objective Amygdala− ventrolateral prefrontal cortex (VLPFC) circuitry is disrupted in
pediatric anxiety disorders, yet how selective serotonin reuptake inhibitors (SSRIs) affect this …

OBJECTIVE: This article presents the results from a prospective, randomized, double-blind,
placebo-controlled trial of escitalopram in adolescent patients with major depressive …

Objective: The purpose of this study was to evaluate the extended efficacy, safety, and
tolerability of escitalopram relative to placebo in adolescents with major depressive disorder …

OBJECTIVE: Escitalopram is a selective serotonin reuptake inhibitor antidepressant
indicated for use in adults. This trial examined the efficacy and safety of escitalopram in …

Abstract Objective: Cytochrome P4502C19 (CYP2C19) is a highly polymorphic gene that
encodes an enzyme that metabolizes escitalopram and sertraline, two selective serotonin …

Escitalopram has been shown in clinical trials to improve anxiety symptoms associated with
depression, panic disorder, and social anxiety disorder. This study was designed to evaluate …

BACKGROUND: Escitalopram 10 mg/day is an effective and well-tolerated antidepressant.
Three randomized controlled trials recently evaluated the safety and efficacy of escitalopram …